0 Comentários
0 Compartilhamentos
400 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça o login para curtir, compartilhar e comentar!
-
Monoclonal Antibodies Market Insights: Growth, Share, Value, Size, and Analysis" Global Monoclonal Antibodies Market Size, Share, and Trends Analysis Report—Industry Overview and Forecast to 2032 Executive Summary: Global monoclonal antibodies market size was valued at USD 263.22 billion in 2024 and is projected to reach USD 719.81 billion by 2032, with a CAGR of 13.40% during the forecast period of 2025 to 2032. Global Monoclonal Antibodies...0 Comentários 0 Compartilhamentos 436 Visualizações 0 Anterior
-
Monoclonal Antibodies Market Opportunities, Industry Statistics, Trends, Revenue Analysis"Executive Summary: Global monoclonal antibodies market size was valued at USD 263.22 billion in 2024 and is projected to reach USD 719.81 billion by 2032, with a CAGR of 13.40% during the forecast period of 2025 to 2032. The Monoclonal Antibodies Market is experiencing unprecedented growth driven by rapid technological advancements, evolving consumer preferences, and...0 Comentários 0 Compartilhamentos 341 Visualizações 0 Anterior
-
Global Cancer Monoclonal Antibodies Market Revenue Forecast: Growth, Share, Value, and Trends"Executive Summary Cancer Monoclonal Antibodies Market : The Global Cancer Monoclonal Antibodies Market size in 2023 is USD 53.33 billion. The market share is projected to grow at a CAGR of 14.00% and reach USD 133.45 billion by 2031. Cancer Monoclonal Antibodies Market research report, comprehensive analysis of the market structure along with forecast of the various...0 Comentários 0 Compartilhamentos 171 Visualizações 0 Anterior
-
Research Antibodies Market Companies: Growth, Share, Value, Size, and Insights"Research Antibodies Market Size, Share, and Trends Analysis Report—Industry Overview and Forecast to 2030 The Laboratory Antibodies Market is witnessing significant growth, driven by evolving consumer demands, technological advancements, and expanding global trade. Leading market research companies indicate that the Biotech Antibody Market is expected to experience steady...0 Comentários 0 Compartilhamentos 739 Visualizações 0 Anterior
-
Asia-Pacific Biologics Market Revenue Forecast: Growth, Share, Value, and Trends"Asia-Pacific Biologics Market Size, Share, and Trends Analysis Report—Industry Overview and Forecast to 2030 The APAC Biopharmaceuticals Market is witnessing strong growth across multiple sectors, including [industry name], where demand is rising due to innovation and market expansion. Market research data indicates that businesses in the Biotechnology Drug Industry are...0 Comentários 0 Compartilhamentos 550 Visualizações 0 Anterior
-
Biologics Drive Global Growth in Protein Therapeutics Market"Executive Summary Protein Therapeutics Market : CAGR Value Data Bridge Market Research analyses that the protein global therapeutics market which was USD 115.17 billion in 2022, is expected to reach USD 290.74 billion by 2030, and is expected to undergo a CAGR of 6.68% during the forecast period 2023-2030. The study and analysis conducted in this industry report also helps to...0 Comentários 0 Compartilhamentos 49 Visualizações 0 Anterior
-
EGFR Inhibitors Market Advances with Growing Applications in Targeted Cancer Therapies"Global Epidermal Growth Factor Receptor Inhibitors Market Size, Share, and Trends Analysis Report—Industry Overview and Forecast to 2032 Executive Summary: The global epidermal growth factor receptor inhibitors market size was valued at USD 14.10 billion in 2024 and is projected to reach USD 28.10 billion by 2032, with a CAGR of 9.00% during the forecast period of 2025 to 2032....0 Comentários 0 Compartilhamentos 376 Visualizações 0 Anterior
-
EGFR Inhibitors Market Strengthens Amid Rising Cancer Incidence and Breakthrough Targeted Therapies"Epidermal Growth Factor Receptor Inhibitors Market Size, Share, and Trends Analysis Report—Industry Overview and Forecast to 2032 According to Data Bridge Market Research firms, the EGFR Targeted Therapies is set to achieve robust growth, supported by emerging economies and digital transformation. Companies operating in the Cancer Growth Receptor Blockers are leveraging...0 Comentários 0 Compartilhamentos 512 Visualizações 0 Anterior
-
PCSK9 Inhibitors Market Driven by Cardiovascular Disease PrevalencePCSK9 inhibitors are a class of lipid-lowering biologics designed to target proprotein convertase subtilisin/kexin type 9, offering a potent reduction in low-density lipoprotein (LDL) cholesterol for patients at high cardiovascular risk. Administered via subcutaneous injection, these monoclonal antibodies and small molecules block PCSK9 interaction with LDL receptors, enhancing receptor...0 Comentários 0 Compartilhamentos 442 Visualizações 0 Anterior